Gilead’s Earnings Are Hit by Patent Settlement. The Stock Falls. | Barron’s

GlaxoSmithKline disclosed a legal settlement with Gilead. Dreamstime. Gilead Sciences gave investors a double dose of bad news on Tuesday. Shares …